AKM OLMESARTAN AMLODIPINE (Pharmacor Pty Ltd)
Product name
AKM OLMESARTAN AMLODIPINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
148 working days (255)
Active ingredients
amlodipine besilate; olmesartan medoxomil
Registration type
New generic medicine
Indication
AKM OLMESARTAN AMLODIPINE (tablets) is indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.